NEOGEN CORP

NEOG · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $2.0B · 1,456 employees
213
SEC Filings
$8.92
Close 2026-06-01
1,456
Employees

Business Summary

Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Our Food Safety segment consists primarily of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and rumi...

Latest Stock Quote

NEOG 2026-06-01 $8.92 O:$8.82 H:$9.005 L:$8.745 Vol:2.8M VWAP:$8.9114
origin leaf: e0499bf4f489ca8dc44583ea16169a058fe22fc3e014cb86857cb71b9452b587

Next Earnings

Q2 FY2026 — expected 2026-09-20

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-07-302025-05-310000950170-25-100064EDGAR52K words
2024-07-302024-05-310000950170-24-087670EDGAR
2023-08-152023-05-310000950170-23-042861EDGAR
2022-07-272022-05-310001193125-22-202902EDGAR
2021-07-302021-05-310001193125-21-230829EDGAR
2020-07-302020-05-310001193125-20-204007EDGAR
2019-07-302019-05-310001193125-19-206929EDGAR
2018-07-272018-05-310001193125-18-229573EDGAR
2017-07-282017-05-310001193125-17-240208EDGAR
2016-07-292016-05-310001193125-16-664134EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-01-082025-11-300001193125-26-007682EDGAR19K words
2025-10-092025-08-310001193125-25-235720EDGAR
2025-04-092025-02-280000950170-25-052497EDGAR
2025-01-152024-11-300000950170-25-005818EDGAR
2024-10-102024-08-310000950170-24-114022EDGAR
2024-04-092024-02-290000950170-24-042952EDGAR
2024-01-092023-11-300000950170-24-003320EDGAR
2023-10-102023-08-310000950170-23-052646EDGAR
2023-04-042023-02-280000950170-23-011785EDGAR
2023-01-092022-11-300001193125-23-004875EDGAR
2022-09-302022-08-310001193125-22-255421EDGAR
2022-04-012022-02-280001193125-22-093901EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130470EDGAR0K words
2026-01-080001193125-26-006990EDGAR
2025-10-300001193125-25-257565EDGAR
2025-10-270001193125-25-250823EDGAR
2025-10-090001193125-25-235081EDGAR
2025-09-150001193125-25-203554EDGAR
2025-08-210000950170-25-110547EDGAR
2025-08-140000950170-25-108900EDGAR
2025-07-290000950170-25-099379EDGAR
2025-07-240000950170-25-098159EDGAR

213 total filings indexed. 181 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0000711377
TickerNEOG
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedMI
Websitehttps://www.neogen.com
Listed1989-08-23

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: cbdfc2661fb3d59d36c4378ed9b95a2fe355163917f980560942cbba46939a3e
parent: 084308648b87871687040b2d92e651df53f717cffe16f16b67bbc3c49d63685f
content hash: cb685e0f99885e17c3324c89b9e822c2cbbefba51b6fa623a2b175d2dcb93ab4
signed: 2026-06-02T19:02:01.413Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf